|
1. Adenovirus Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
-- |
|
Barr Labs/Teva Pharmaceuticals (under contract with US Army) |
Mar. 2011 |
|
human-diploid fibroblast cell cultures (WI-38), Dulbecco's Modified Eagle's Medium, fetal bovine serum, sodium bicarbonate |
sucrose,
D-mannose, D-fructose, dextrose, potassium phosphate, plasdone C,
anhydrous lactose, micro crystalline cellulose, polacrilin potassium,
magnesium stearate, cellulose acetate phthalate, alcohol, acetone,
castor oil, FD&C Yellow #6 aluminum lake dye, human serum albumin |
|
2. Anthrax Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Emergent Biosolutions |
Dec. 2008 |
|
amino acids, vitamins, inorganic salts and sugars |
aluminum hydroxide, benzethonium chloride, formaldehyde |
|
3. BCG Vaccine
(tuberculosis) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Organon Teknika Corp. |
Feb. 2009 |
|
glycerin, asparagine, citric acid, potassium phosphate, magnesium sulfate, iron ammonium citrate |
lactose, saline |
|
4. DT Vaccine
(diphtheria & tetanus) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Diphtheria and Tetanus Toxoids Absorbed |
-- |
|
Sanofi Pasteur, Ltd. |
Dec. 2005 |
|
peptone, bovine extract, modified Mueller and Miller medium |
aluminum sulfate, formaldehyde, thimerosal (trace) |
|
5. DTap Vaccine
(diphtheria, tetanus, & pertussis) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Diphtheria and Tetanus Toxoids and Accellular Pertussis Vaccine Absorbed |
Daptacel |
|
Sanofi Pasteur, Ltd. |
July 2011 |
|
Stainer-Scholte medium, modified Mueller’s growth medium, modified Mueller-Miller casamino acid medium (without beef heart infusion), casamino acids, dimethyl-beta-cyclodextrin, aluminum sulfate, aluminum phosphate |
aluminum phosphate, formaldehyde, glutaraldehyde, 2-Phenoxyethanol |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed |
Infanrix |
|
GlaxoSmithKline Biologicals |
Nov. 2011 |
|
formaldehyde, glutaraldehyde, Fenton medium (containing bovine extract), modified Latham medium (derived from bovine casein), modified Stainer-Scholte liquid medium |
aluminum hydroxide, polysorbate 80, sodium chloride, formaldehyde |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed |
Tripedia |
|
Sanofi Pasteur, Inc. |
Dec. 2005 |
|
sodium phosphate, peptone-based medium, bovine extract (US sourced), formaldehyde, ammonium sulfate, aluminum potassium sulfate, modified Mueller and Miller medium, modified Stainer-Scholte medium, isotonic sodium, chloride solution, sodium phosphate |
thimerosal (trace), gelatin, polysorbate 80 (Tween 80), formaldehyde, aluminum |
|
6. DTap-IPV Vaccine
(diphtheria, tetanus, pertussis, & polio) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine |
Kinrix |
|
GlaxoSmithKline Biologicals |
Nov. 2011 |
|
formaldehyde, glutaraldehyde, aluminum hydroxide, Vero cells, calf serum, lactalbumin hydrolysate, Fenton medium (containing bovine extract), modified Latham medium (derived from bovine casein), modified Stainer-Scholte liquid medium |
polysorbate 80 (Tween 80), neomycin sulfate, polymyxin B, aluminum hydroxide, sodium chloride, formaldehyde |
|
7. DTap-HepB-IPV Vaccine
(diphtheria, tetanus, pertussis, hepatitis B, & polio) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Diphtheria
and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B
(Recombinant) and Inactivated Poliovirus Vaccine Combined |
Pediarix |
|
GlaxoSmithKline Biologicals |
Nov. 2011 |
|
formaldehyde, gluteraldehyde, aluminum hydroxide, aluminum phosphate, lactalbumin hydrolysate, calf serum, Fenton medium (containing bovine extract), modified Latham medium (derived from bovine casein), modified Stainer-Scholte liquid medium, Vero cells |
polysorbate 80 (Tween 80), neomycin sulfate, polymyxin B, yeast protein, aluminum salts, sodium chloride, formaldehyde |
|
8. DTap-IPV/Hib Vaccine
(diphtheria, tetanus, pertussis, polio, & haemophilus influenzae type B) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Diphtheria
and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated
Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)
Vaccine |
Pentacel |
|
Sanofi Pasteur, Inc. |
July 2011 |
|
aluminum phosphate, formaldehyde, gutaraldehyde, 2-phenoxethanol, Mueller’s Growth Medium, Mueller-Miller casamino acid medium (without beef heart infusion), Stainer-Scholte medium, casamino acids, dimethyl-beta-cyclodextrin), MRC-5 cells, CMRL 1969 medium (supplemented with calf serum), ammonium sulfate, water |
polysorbate 80, bovine serum albumin, neomycin, polymyxin B sulfate, aluminum phosphate, formaldehyde, 2-phenoxethanol |
|
9. Hib Vaccine
(haemophilus influenzae type B) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
ActHIB |
|
Sanofi Pasteur, Inc. |
May 2009 |
|
ammonium sulfate, formalin, Modified Mueller and Miller medium, saline diluent, formaldehyde |
sucrose, purified capsular polysaccharide |
Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
Hiberix |
|
GlaxoSmithKline Biologicals |
Dec. 2010 |
|
formaldehyde, synthetic medium, semi-synthetic medium |
lactose, sodium chloride, formaldehyde, purified capsular polysaccharide |
Haemophilus B Conjugate Vaccine (Meningococcal Protein Conjugate) |
Liquid PedvaxHIB |
|
Merck Sharp & Dohme Corp. |
Dec. 2010 |
|
complex fermentation media, ethanol |
amorphous aluminum hydroxphosphate sulfate, sodium chloride |
|
10. Hib/Hep B Vaccine
(haemophilus influenzae type B & hepatitis B) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine |
COMVAX |
|
Merck & Co., Inc. |
Dec. 2010 |
|
yeast
(vaccine contains no detectable yeast DNA), nicotinamide adenine
dinucleotide, hemin chloride, soy peptone, dextrose, mineral salts,
amino acids, formaldehyde, potassium aluminum sulfate, amorphous aluminum hydroxyphosphate sulfate, sodium borate |
aluminum hydroxyphosphate sulphate, sodium chloride, formaldehyde |
|
11. Hep A Vaccine
(hepatitis A) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Hepatitis A Vaccine, Inactivated |
Havrix |
|
GlaxoSmithKline Biologicals |
July 2011 |
|
MRC-5 cells, formaldehyde |
aluminum hydroxide, amino acid supplement, polysorbate 20, formalin, neomycin sulfate, phosphate buffered saline, residual MRC-5 cellular proteins, aminoglycoside antibiotic |
Hepatitis A Vaccine, Inactivated |
VAQTA |
|
Merck & Co., Inc. |
Dec. 2010 |
|
amorphous aluminum hydroxyphosphate sulfate, formaldehyde, neomycin, MRC-5 fibroblasts |
bovine albumin, sodium borate, formaldehyde, non-viral proteins, sodium chloride, neomycin |
|
12. Hep B Vaccine
(hepatitis B) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
GlaxoSmithKline Biologicals |
Oct. 2011 |
|
-- |
aluminum hydroxide, yeast protein, phosphate buffers, sodium chloride, disodium phosphate, dihydrate, sodium dihydrogen |
|
Merck & Co., Inc. |
July 2011 |
|
yeast protein, soy peptone, dextrose, amino acids, mineral salts, potassium aluminum sulfate, amorphous aluminum hydroxyphosphate sulfate, formaldehyde |
formaldehyde, yeast protein |
|
13. Hep A/Hep B Vaccine
(hepatitis A & hepatitis B) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine |
Twinrix |
|
GlaxoSmithKline Biologicals |
Nov. 2011 |
|
yeast protein, aluminum phosphate, aluminum hydroxide, amino acids, phosphate buffer, polysorbate 20, MRC-5 cells, formaldehyde, sodium chloride |
neomycin sulfate, MRC-5 cell proteins, formaldehyde, yeast protein, water |
|
14. HPV Vaccine
(human papillomavirus) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant |
Cervarix |
|
GlaxoSmithKline Biologicals |
July 2011 |
|
vitamins, amino acids, lipids, mineral salts, aluminum (as hydroxide salt), sodium dihydrogen phosphate dehydrate, |
insect cell and viral protein, sodium chloride, water, aluminum hydroxide, bacterial cell protein |
Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant |
Gardasil |
|
Merck & Co., Inc. |
Mar. 2011 |
|
yeast protein, vitamins, amino acids, mineral salts, carbohydrates, amorphous aluminum hydroxyphosphate sulfate, aluminum-containing adjuvant |
L-histidine, polysorbate 80, sodium borate, amorphous aluminum hydroxyphosphate sulfate adjuvant, sodium chloride, yeast protein, water |
|
15. Influenza Vaccine
(Flu) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
|
beta-propiolactone, sodium taurodeoxycholate, allantoic fluid of embryonated chicken eggs, sucrose density agent, phosphate buffered isotonic solution |
thimerosol
(multi-dose vials only), monobasic sodium phosphate, dibasic sodium
phosphate, monobasic potassium phosphate, potassium chloride, calcium
chloride, sodium taurodeoxycholate, neomycin sulfate, polymyxin B, ovalbumin, mercury, sodium, chloride, beta-propiolacton |
|
Novartis Vaccines and Diagnostics, Inc. |
Feb. 21, 2013 |
|
kanamycin, neomycin sulfate, cetyltrimethylammonium bromide, allantoic cavity of embryonated hens' eggs |
formaldehyde, egg protein, polysorbate 80, CTAB, neomycin, kanmycin |
|
GlaxoSmithKline Biologicals |
May 2013 |
|
embryonated chicken eggs, sodium phosphate-buffered isotonic sodium chloride solution, sodium deoxycholate, formaldehyde, |
octoxynol-10 (Triton X-100), a-tocopheryl hydrogen succinate, polysorbate 80 (Tween 80), hydrocortisone, gentamicin sulfate, ovalbumin, hydrocortisone, formaldehyde, sodium deoxycholate |
|
Protein Sciences Corporation |
Oct. 2013 |
|
HA insect cell (fall armyworm, Spodoptera frugiperda) proteins, lipids, vitamins, amino acids, mineral salts |
sodium chloride, monobasic sodium phosphate, dibasic sodium phosphate, polysorbate 20 (Tween 20), host cell proteins, baculovirus, Triton X-100 |
|
Novartis Vaccines and Diagnostics Limited |
Feb. 2013 |
|
Madin Darby Canine Kidney (MDCK) cells, B-propiolactone, cetyltrimethylammonium bromide |
residual MDCK cell protein, other cell proteins, MDCK cell DNA, polysorbate 80, cetyltrimethylammonium bromide, B-propiolactone |
|
ID Biomedical Corporation of Quebec |
2013-2014 |
|
allantoic cavity of embryonated hens' eggs, formaldehyde, sodium deocycholate |
phosphate-buffered saline solution, thimerosal, ovalbumin, formaldehyde, sodium deoxycholate |
|
|
SPF (specific pathogen-free) eggs, stabilizing buffer |
monosodium glutamate, hydrolyzed porcine gelatin, arginine, sucrose, dibasic potassium phosphate, monobasic potassium phosphate, ovalbumin, gentamicin sulfate, ethylenediaminetetraacetic acid (EDTA) |
|
Novartis Vaccines and Diagnostics Limited |
Feb. 26, 2013 |
|
allantoic cavity of embryonated hens' eggs, neomycin, polymyxin, betapropiolactone, nonylphenol ethoxylate, |
phosphate-buffered saline, thimerosal, egg proteins, polymyxin, neomycin, betapropiolactone, nonylphenol ethoxylate |
|
Sanofi Pasteur, Inc. |
June 2013 |
|
embryonated chicken eggs, Octylphenol Ethoxylate (Triton X-100), sodium phosphate-buffered isotonic sodium chloride solution, formaldehyde |
formaldehyde,
octylphenol ethoxylate (Triton X-100), sodium phosphate-buffered
isotonic sodium chloride solution, gelatin (standard formulation only), thimerosal (standard dosage multi-dose vial only) |
|
16. Japanese Encephalitis Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Japanese Encephalitis Vaccine, Inactivated, Adsorbed |
Ixiaro |
|
Intercell Biomedical |
Sep. 2010 |
|
Vero cells, protamine sulfate, formaldehyde, aluminum hydroxide |
aluminum hydroxide, formaldehyde, bovine serum albumin, host cell DNA, sodium metabisulphate, host cell proteins, protamine sulphate |
Japanese Encephalitis Vaccine, Inactivated |
JE-Vax |
|
Research Foundation for Microbial Diseases of Osaka University |
Dec. 2005 |
|
mice (brains are innoculated with the virus), phosphate-buffered saline, formaldehyde, 40% w/v sucrose |
thimerosal, Sterile Water for Injection, gelatin, formaldehyde, v/v Polysorbate 80, mouse serum protein |
|
17. Measles Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Merck &Co., Inc. |
Feb. 2006 |
|
chick embryo cell culture, buffered salt solution, vitamins, amino acides, fetal bovine serum, SPGA (sucrose, phosphate, gluatamate, human albumin), neomycin |
sorbitol, sodium phosphate, sucrose, sodium, chloride, hydrolyzed gelatin, human albumin, fetal bovine serum, neomycin, other buffer and media ingredients |
|
18. Meningococcal Vaccine
(meningitis) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine |
MCV4-Menactra |
|
Sanofi Pasteur Inc. |
Nov. 2011 |
|
Mueller Hinton agar, Watson Scherp media, Mueller and Miller medium, formaldehyde, ammonium sulfate |
formaldehyde, sodium phosphate buffered isotonic sodium chloride solution, |
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
MenHibrix |
|
GlaxoSmithKline Biologicals |
2012 |
|
synthetic medium, formaldehyde, sucrose, saline diluent |
Tris (trometamol)-HCL, sucrose, residual formaldehyde |
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
Menveo |
|
Novartis Vaccines and Diagnostics, Inc. |
Mar. 2011 |
|
Franz Complete medium, formaldehyde, CY medium (contains yeast extracts and amino acids), |
formaldehyde |
|
Sanofi Pasteur Inc. |
Jan. 2009 |
|
Mueller Hinton casein agar, Watson Scherp casamino acid media |
distilled water, thimersol, polysaccharide from serogroups A, C, Y, and w-135, mercury, lactose |
|
19. MMR Vaccine
(measles, mumps, & rubella) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Measles, Mumps, and Rubella Virus Vaccine, Live |
M-M-R-II |
|
Merck and Co., Inc. |
Dec. 2010 |
|
chick embryo cell culture, WI-38 human diploid lung fibroblasts, Medium 199 (containing vitamins, amino acids, fetal bovine serum, SPGA (sucrose, phosphate, glutamate, recomninant human albumin), neomycin), Minimum Essential Medium (containing vitamins, amino acids, fetal bovine serum, recombinant human albumin, neomycin), sorbitol, hydrolyzed gelatin stabilizer |
sorbitol, sodium phosphate, sucrose, sodium chloride, hydrolyzed gelatin, recombinant human albumin, fetal bovine serum, other buffer and media ingredients, neomycin |
|
Merck and Co., Inc. |
Aug. 2011 |
|
chick embryo cell culture, WI-38 human diploid lung fibroblasts, MRC-5 cells, bovine serum, human albumin |
sucrose, hydrolized gelatin, urea, sodium chloride, sorbitol, monodium L-glutamate, sodium phosphate, human albumin, sodium bicarbonate, potassium phosphate, potassium chloride, residual components of MRC-5 cells (including DNA and protein), neomycin, bovine serum albumin, other buffer and media ingredients, sodium phosphate dibasic, potassium phosphate monobasic, potassium phosphate dibasic |
|
20. Pneumococcal Vaccine
(pneumonia) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein) |
Prevnar |
|
Wyeth Pharmaceuticals Inc. |
Mar. 2009 |
|
soy peptone broth, casamino acids and yeast extract-based medium, ammonium sulfate, saccharides |
aluminum (as aluminum phosphate adjuvant) |
Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) |
Prevnar 13 |
|
Wyeth Pharmaceuticals Inc. |
Jan. 2012 |
|
soy peptone broth, casamino acids and yeast extract-based medium, ammonium sulfate |
polysorbate 80, succinate buffer, aluminum (as aluminum phosphate adjuvant) |
|
Merck & Co., Inc. |
Oct. 2011 |
|
-- |
isotonic saline solution, phenol |
|
21. Polio Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Poliovirus Vaccine Inactivated (Monkey Kidney Cell) |
IPOL |
|
Sanofi Pasteur, SA |
Dec. 2005 |
|
Vero cells, Eagle MEM modified medium, newborn calf serum, M-199 (without calf serum) |
2-phenoxyethanol, formaldehyde, neomycin, streptomycin, polymyxin B, residual calf serum |
|
22. Rabies Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Sanofi Pasteur, SA |
Dec. 2005 |
|
MRC-5 cells, beta-propiolactone |
human albumin, neomycin sulfate, phenol red indicator, beta-propiolactone |
|
Novartis Vaccines and Diagnostics |
Oct. 2006 |
|
chicken fibroblasts, synthetic cell culture medium, human albumin, polygeline (processed bovine gelatin), antibiotics, B-propiolactone, sucrose density-gradient, buffered polygeline, potassium glutamate |
polygeline (processed bovine gelatin), human serum albumin, potassium glutamate, sodium EDTA, bovine serum, chicken protein, neomycin, chlortracycline, amphotericin B, Water for Injection |
|
23. Rotavirus Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Rotavirus Vaccine, Live, Oral, Pentavalent |
RotaTeq |
|
Merck & Co., Inc. |
Sep. 2011 |
|
Vero cells, buffered stabilizer, porcine-derived materials |
sucrose, sodium citrate, sodium phosphate monobasic monohydrate, sodium hydroxide, polysorbate 80, cell culture media, fetal bovine serum (trace), DNA for porcine circoviruses |
Rotavirus Vaccine, Live, Oral |
Rotarix |
|
GlaxoSmithKline Biologicals |
Feb. 2011 |
|
Vero cells, porcine-derived materials |
amino acids, dextran, Dulbecco's Modified Eagle Medium (sodium
chloride, potassium chloride, magnesium sulfate, ferric (III) nitrate,
sodium phosphate, sodium pyruvate, D-glucose, concentrated vitamin
solution, L-cystine, L-tyrosine, amino acids solution, L-glutamine,
calcium chloride, sodium hydrogenocarbonate, phenol red), sorbitol,
sucrose, calcium carbonate, sterile water, xanthan |
|
24. Rubella Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Merck & Co., Inc. |
Feb. 2006 |
|
WI-38 human diploid lung fibroblasts, Minimum Essential Medium (MEM; buffered salt solution (vitamins, amino acids, bovine serum), human serum albumin, neomycin), sorbitol, hydrolyzed gelatin stabilizer |
sorbitol, sodium phosphate, sucrose, sodium chloride, hydrolyzed gelatin, human albumin, fetal bovine serum, other buffer and media ingredients, neomycin |
|
25. Smallpox Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Smallpox (Vaccinia) Vaccine, Live |
ACAM2000 |
|
Sanofi Pasteur Biologics Co. |
Aug. 2007 |
|
Vero cells, human serum albumin, sodium chloride, mannitol USP, meomycin, polymyxin B |
glycerin USP, phenol USP in Water for Injection USP |
|
26. TD Vaccine
(tetanus & diphtheria) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Tetanus and Diphtheria Toxoids Adsorbed For Adult Use |
DECAVAC |
|
Sanofi Pasteur, Inc. |
Mar. 2011 |
|
Mueller and Miller medium, peptone-based medium, extract of bovine muscle tissue, formaldehyde, ammonium sulfate |
thimerosal, aluminum potassium sulfate adjuvant, residual formaldehyde |
Tetanus and Diphtheria Toxoids Adsorbed For Adult Use |
TENIVAC |
|
Sanofi Pasteur, Ltd. |
Dec. 2010 |
|
modified Mueller-Miller casamino acid medium without beef heart infusion, formaldehyde, ammonium sulfate, modified Mueller's growth medium, aluminum phosphate, 2-phenoxyethanol, sodium chloride |
aluminum phosphate, residual formaldehyde, 2-phenoxyethanol, sodium chloride, water for injection |
Tetanus and Diphtheria Toxoids, Adsorbed |
-- |
|
|
modified Mueller's media (contains bovine extracts), formaldehyde, ammonium sulfate, aluminum phosphate |
aluminum adjuvant, residual formaldehyde, thimerosal |
|
Sanofi Pasteur, Inc. |
Dec. 2005 |
|
peptone-based medium, formaldehyde, ammonium sulfate, physiological saline solution |
thimerosal, formaldehyde |
Tetanus Toxoid Absorbed |
-- |
|
Sanofi Pasteur, Inc. |
July 2005 |
|
peptone-based medium (contains extract of bovine muscle tissue), formaldehyde, ammonium sulfate, aluminum potassium sulfate (alum) |
thimerosal, physiological saline solution |
|
27. Tdap Vaccine
(tetanus, diphtheria, & pertussis) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
Adacel |
|
Sanofi Pasteur, Ltd. |
Dec. 2010 |
|
Stainer-Scholte medium, casamino acids, dimethyl-beta-cyclodextrin, glutaraldehyde, formaldehyde, aluminum phosphate, modified Mueller-Miller casamino acid medium without beef heart infusion, ammonium sulfate, 2-phenoxyethanol, water for injection |
aluminum phosphate, residual formaldehyde, residual glutaraldehyde, 2-phenoxyethanol |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
Boostrix |
|
GlaxoSmithKline Biologicals |
Jan. 2012 |
|
modified Latham medium derived from bovine casein, Fenton medium containing bovine extract, formaldehyde, Stainer-Scholte liquid medium, glutaraldehyde, aluminum hydroxide |
aluminum hydroxide, sodium chloride, residual formaldehyde, polysorbate 80 (Tween 80) |
|
28. Typhoid Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Sanofi Pasteur SA |
Dec. 2005 |
|
semi-synthetic medium without animal proteins, hexadecyltrimethylammonium bromide |
residual
polydimethylsoloxane or fatty-acid ester-cased antifoam, isotonic
phosphate buffered saline, sodium chloride, disodium phosphate,
monosodium phosphate, sterile water for injection |
Typhoid Vaccine Live Oral Ty21a |
Vivotif |
|
Berna Biotech, Ltd. |
Aug. 2006 |
|
yeast extract, casein, dextrose, and galactose, sucrose, ascorbic acid, amino acids, lactose, magnesium stearate |
sucrose, ascorbic acid, amino acid mixture, lactose, magnesium stearate |
|
29. Varicella Vaccine
(chickenpox) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Merck & Co., Inc. |
Aug. 2011 |
|
human embryonic lung cell cultures, embryonic guinea pig cell cultures, WI-38 human diploid cell cultures, MRC-5 human diploid cell cultures, sucrose, phosphate, glutamate, processed gelatin, urea |
sucrose,
hydrolyzed gelatin, urea, sodium chloride, monosodium L-glutamate,
sodium phosphate dibasic, potassium phosphate monobasic, potassium
chloride, residual components of MRC-5 cells (DNA, protein), neomycin, bovine calf serum, sodium phosphate monobasic, EDTA, fetal bovine serum |
|
30. Yellow Fever Vaccine |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Sanofi Pasteur, Inc. |
Jan. 2010 |
|
living avian leukosis virus-free (ALV-free) chicken embryos |
sorbitol, gelatin |
|
31. Zoster Vaccine
(shingles) |
PROPER NAME |
COMMERCIAL NAME
(click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS
(not in order of quantity; see package insert for quantities) |
|
Merck & Co., Inc. |
June 2011 |
|
-- |
sucrose, hydrolyzed porcine gelatin,
sodium chloride, monosodium L-glutamate, sodium phosphate dibasic,
potassium phosphate monobasic, potassium chloride, residual components
of MRC-5 cells (DNA, protein), neomycin, bovine calf serum |
No comments:
Post a Comment